We are live on ! Find out more
Rafferty Asset Management

Rafferty Asset Management Portfolio holdings

AUM $24.6B
1-Year Est. Return 47.06%
This Fund
S&P 500
This Quarter Est. Return
+7.65%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$8.27B
AUM Growth
+$1.17B
Cap. Flow
+$791M
Cap. Flow %
9.57%
Top 10 Hldgs %
43.67%
Holding
1,071
New
101
Increased
574
Reduced
272
Closed
122

Sector Composition

Rank Sector Weight
1 Technology 27.46%
2 Financials 14.83%
3 Healthcare 4.08%
4 Consumer Discretionary 3.56%
5 Industrials 3.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APLS
401
DELISTED
Apellis Pharmaceuticals
APLS
$2.09M 0.03%
69,229
+38,410
+125% +$1.15M
TCF
402
DELISTED
TCF Financial Corporation Common Stock
TCF
$2.09M 0.03%
89,443
+23,113
+35% +$619K
VOYA icon
403
Voya Financial
VOYA
$9.01B
$2.08M 0.03%
43,395
+17,445
+67% +$859K
TBIO
404
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$2.08M 0.03%
152,743
+136,710
+853% +$2.11M
LPLA icon
405
LPL Financial
LPLA
$28.3B
$2.08M 0.03%
27,108
+10,947
+68% +$869K
EQR icon
406
Equity Residential
EQR
$24.9B
$2.08M 0.03%
40,423
-64,002
-61% -$3.54M
GBT
407
DELISTED
Global Blood Therapeutics, Inc.
GBT
$2.07M 0.03%
37,607
+22,359
+147% +$1.42M
IOVA icon
408
Iovance Biotherapeutics
IOVA
$1.82B
$2.06M 0.02%
62,592
+30,227
+93% +$927K
CCS icon
409
Century Communities
CCS
$1.91B
$2.05M 0.02%
48,509
+7,852
+19% +$287K
KPTI icon
410
Karyopharm Therapeutics
KPTI
$43.5M
$2.04M 0.02%
9,315
+5,503
+144% +$1.35M
STL
411
DELISTED
Sterling Bancorp
STL
$2.04M 0.02%
193,881
+59,932
+45% +$679K
PTCT icon
412
PTC Therapeutics
PTCT
$5.68B
$2.03M 0.02%
43,513
+24,122
+124% +$1.19M
BIP icon
413
Brookfield Infrastructure Partners
BIP
$19.2B
$2.02M 0.02%
+63,659
New +$1.87M
SEIC icon
414
SEI Investments
SEIC
$12.4B
$2.02M 0.02%
39,827
+16,004
+67% +$846K
RBC icon
415
RBC Bearings
RBC
$17.4B
$2.02M 0.02%
16,659
+2,777
+20% +$356K
CIT
416
DELISTED
CIT Group Inc.
CIT
$2M 0.02%
112,968
+48,726
+76% +$930K
MNTA
417
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$2M 0.02%
38,099
+7,333
+24% +$304K
EXP icon
418
Eagle Materials
EXP
$6.29B
$1.98M 0.02%
22,951
+3,396
+17% +$274K
JKHY icon
419
Jack Henry & Associates
JKHY
$10.9B
$1.98M 0.02%
12,184
-12,776
-51% -$2.22M
KSU
420
DELISTED
Kansas City Southern
KSU
$1.97M 0.02%
10,917
-924
-8% -$160K
ICPT
421
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$1.97M 0.02%
47,581
+34,877
+275% +$1.6M
GEN icon
422
Gen Digital
GEN
$16.4B
$1.96M 0.02%
93,925
+28,317
+43% +$613K
UTHR icon
423
United Therapeutics
UTHR
$22B
$1.96M 0.02%
19,355
+11,084
+134% +$1.22M
ESPR
424
DELISTED
Esperion Therapeutics
ESPR
$1.95M 0.02%
52,436
+30,476
+139% +$1.21M
KYNB
425
Kyntra Bio
KYNB
$27.2M
$1.94M 0.02%
1,882
+881
+88% +$948K

Similar funds

Rafferty Asset Management's Q3 2020 Portfolio in Review

As of Q3 2020, Rafferty Asset Management held 1,071 positions worth $8.27B, up 17% from $7.1B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Rafferty Asset Management deployed $791M of net new capital in Q3 2020, opening 101 new positions and adding to 574 existing holdings. Its largest new stake was INPHI CORPORATION: 63,139 shares worth $7.09M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $189M trimmed.

  • Rafferty Asset Management's largest Q3 2020 buy was INPHI CORPORATION: 63,139 shares worth $7.09M.
  • Rafferty Asset Management added most to VanEck Gold Miners ETF in Q3 2020, an estimated $299M increase.
  • Rafferty Asset Management's biggest Q3 2020 reduction was iShares Russell 2000 ETF, cutting an estimated $189M.
  • Rafferty Asset Management fully exited iShares Russell 1000 ETF in Q3 2020, selling an estimated $19.9M.
  • Rafferty Asset Management's ten largest holdings make up 44% of its $8.27B portfolio in Q3 2020.
  • Rafferty Asset Management opened 101 new positions and closed 122 in Q3 2020.
  • Rafferty Asset Management's portfolio value rose 17% quarter-over-quarter to $8.27B.

Based on Rafferty Asset Management's 13F filing for Q3 2020, filed 13 Nov 2020.